arrow
A

Albert Gris-Oliver

University of Barcelona
H指数:14
被引数:1,403

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Activated ATF6α is a hepatic tumour driver restricting immunosurveillance

激活的ATF6α 是限制免疫监视的肝肿瘤驱动因素

Nature
IF48.5
2026-02-040
OA
Mutational scanning reveals oncogenic CTNNB1 mutations have diverse effects on signaling

突变扫描显示致癌CTNNB1突变对信号传导有不同的影响

2026-02-020
OAAI
Effective therapeutic targeting of CTNNB1-mutant hepatoblastoma with WNTinib

CTNNB1突变型肝母细胞瘤的有效治疗性靶向WNTinib

2025-12-010
OAAI
Artificial intelligence predicts outcome-related molecular profiles and vascular invasion in hepatocellular carcinoma

人工智能预测肝细胞癌的结局相关分子谱和血管侵犯

2025-09-110
OAAI
Oncogenic role of PMEPA1 and its association with immune exhaustion and TGF-β activation in HCC
2024-11-010
OAAI
AKT-mTORC1 reactivation is the dominant resistance driver for PI3Kβ/AKT inhibitors in PTEN-null breast cancer and can be overcome by combining with Mcl-1 inhibitors
2022-10-148
OAAI
TLR2 and TLR7 mediate distinct immunopathological and antiviral plasmacytoid dendritic cell responses to SARS-CoV-2 infection

TLR2和TLR7介导不同的免疫病理和抗病毒浆细胞样树突状细胞对SARS-CoV-2感染的反应

2022-03-0155
OAAI
PI3K activation promotes resistance to eribulin in HER2-negative breast cancer

PI3K激活促进HER2-negative乳腺癌对eribulin的耐药性

2021-03-1513
OAAI
A RAD51 assay feasible in routine tumor samples calls PARP inhibitor response beyond BRCA mutation

在常规肿瘤样本中可行的RAD51测定呼吁PARP抑制剂反应超出BRCA突变

2018-10-30187
OAAI
In vivo phosphoproteomics reveals kinase activity profiles that predict treatment outcome in triple-negative breast cancer
2018-08-2943
OAAI
RAD51 foci as a functional biomarker of homologous recombination repair and PARP inhibitor resistance in germline BRCA-mutated breast cancer
2018-05-01305
OAAI
PIM1 kinase regulates cell death, tumor growth and chemotherapy response in triple-negative breast cancer (vol 22, pg 1303, 2016)

PIM1激酶调节三阴性乳腺癌的细胞死亡,肿瘤生长和化疗反应 (vol 22,pg 1303,2016)

2017-06-015
OAAI
PIM1 kinase regulates cell death, tumor growth and chemotherapy response in triple-negative breast cancer (vol 22, pg 1303, 2016)

PIM1激酶调节三阴性乳腺癌的细胞死亡,肿瘤生长和化疗反应 (vol 22,pg 1303,2016)

2017-04-013
OAAI
PIM1 kinase regulates cell death, tumor growth and chemotherapy response in triple-negative breast cancer
2016-10-24212
OAAI